Seoulin Bioscience Company Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Seoulin Bioscience Company Limited with three other
companies in this sector in South Korea:
Naturalendo Tech Co Ltd
sales of 44.51 billion Korean Won [US$39.57 million]
Medipost Co Ltd
(37.57 billion Korean Won [US$33.40 million]
of which 64%
was Umbilical Cord Blood), and
(32.52 billion Korean Won [US$28.91 million]
During the year ended December of 2015, sales at
Seoulin Bioscience Company Limited were 41.63 billion Korean Won (US$37.01 million).
increase of 10.5%
versus 2014, when the company's sales were 37.66 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2013, when Seoulin Bioscience Company Limited
reported sales of 42.20 billion Korean Won.
Sales of Healthcare saw an increase
16.6% in 2015, from
1.01 billion Korean Won to 1.17 billion Korean Won.